Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 20, 2015, 43 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $78.70 to $1,311,864,574.80.

Highlighted Stocks Traded by Insiders:

Cytori Therapeutics (CYTX) - FREE Research Report

Lim Kian Thiam, who is 10% Owner at Cytori Therapeutics, sold 600,000 shares at $1.37 on April 20, 2015. Following this transaction, the 10% Owner owned 7.4 million shares meaning that the stake was reduced by 7.5% with the 600,000-share transaction.

The shares most recently traded at $1.10, down $0.27, or 24.63% since the insider transaction. Historical insider transactions for Cytori Therapeutics go as follows:

  • 4-Week # shares bought: 60,000
  • 4-Week # shares sold: 29,145
  • 12-Week # shares bought: 60,000
  • 12-Week # shares sold: 29,145
  • 24-Week # shares bought: 60,000
  • 24-Week # shares sold: 29,145

The average volume for Cytori Therapeutics has been 5.1 million shares per day over the past 30 days. Cytori Therapeutics has a market cap of $120.1 million and is part of the health care sector and drugs industry. Shares are up 129.18% year-to-date as of the close of trading on Monday.

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. Currently, there are 2 analysts who rate Cytori Therapeutics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYTX - FREE

TheStreet Quant Ratings rates Cytori Therapeutics as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full Cytori Therapeutics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Kirkland's (KIRK) - FREE Research Report

Alderson Robert E, who is Director at Kirkland's, sold 30,000 shares at $23.28 on April 20, 2015. Following this transaction, the Director owned 560,143 shares meaning that the stake was reduced by 5.08% with the 30,000-share transaction.

The shares most recently traded at $23.54, up $0.26, or 1.1% since the insider transaction. Historical insider transactions for Kirkland's go as follows:

  • 4-Week # shares sold: 561,804
  • 12-Week # shares sold: 644,870
  • 24-Week # shares sold: 669,870

The average volume for Kirkland's has been 152,200 shares per day over the past 30 days. Kirkland's has a market cap of $398.1 million and is part of the services sector and retail industry. Shares are down 2.75% year-to-date as of the close of trading on Monday.

Kirkland's, Inc. operates as a specialty retailer of home decor and gifts in the United States. The company has a P/E ratio of 23.0. Currently, there are 5 analysts who rate Kirkland's a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KIRK - FREE

TheStreet Quant Ratings rates Kirkland's as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Kirkland's Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Blackstone Mortgage (BXMT) - FREE Research Report

Plavin Stephen D, who is President & CEO at Blackstone Mortgage, bought 24,590 shares at $30.50 on April 20, 2015. Following this transaction, the President & CEO owned 148,545 shares meaning that the stake was boosted by 19.84% with the 24,590-share transaction.

Nash Michael B., who is Director at Blackstone Mortgage, bought 65,574 shares at $30.50 on April 20, 2015. Following this transaction, the Director owned 164,550 shares meaning that the stake was boosted by 66.25% with the 65,574-share transaction.

The shares most recently traded at $31.13, up $0.63, or 2.02% since the insider transaction. Historical insider transactions for Blackstone Mortgage go as follows:

  • 4-Week # shares sold: 1,276
  • 12-Week # shares sold: 1,276
  • 24-Week # shares bought: 65,301
  • 24-Week # shares sold: 2,614

The average volume for Blackstone Mortgage has been 643,400 shares per day over the past 30 days. Blackstone Mortgage has a market cap of $1.8 billion and is part of the financial sector and real estate industry. Shares are up 6.42% year-to-date as of the close of trading on Monday.

Blackstone Mortgage Trust, Inc., a real estate finance company, originates and purchases senior loans collateralized by properties in North America and Europe. It operates through two segments, Loan Origination and CT Legacy Portfolio. The stock currently has a dividend yield of 6.74%. The company has a P/E ratio of 16.6. Currently, there are 6 analysts who rate Blackstone Mortgage a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on BXMT - FREE

TheStreet Quant Ratings rates Blackstone Mortgage as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Blackstone Mortgage Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null